Open company graph database — free web & API
Login

Public Foundation for Microbial Chemistry Research

公益財団法人微生物化学研究会
Ticker
—
Listed market
—
Country
Japan
Employees (non-consolidated)
—
Related companies
0
§01

Basic information

BASIC
Head office
1-1-1 Nihonbashi Motomachi, Chuo-ku, Tokyo
Chief executive
No information
Capital
Employees (non-consolidated)
Employees (consolidated)
Start date
1958-12-10
End date
§02

Websites

1 DOMAINS
§03

Business

9
Discovery and creation of antibiotics and bioactive substancesBasic researchApplied researchCreation of substances and social implementationResearch and development of antimicrobial chemotherapy agentsSale of antimicrobial chemotherapy agentsDiscovery and launch of antimicrobial and anticancer drugsDevelopment and commercialization of enzyme inhibitors as reagentsDevelopment and commercialization of bioactive natural or synthetic reagents
§04

Related companies

0 COMPANIES

—

§05

Network

NETWORK
Drag to move · click to open
§06

History

39 EVENTS

Dr. Hanzō Umezawa (then Director of the Antibiotics Division at the National Institute of Infectious Diseases and Professor at the University of Tokyo Applied Microbiology Institute) and colleagues discovered a new antibiotic, kanamycin. Kanamycin proved highly effective in treating severe infections caused by resistant bacteria at the time.Sources

Kanamycin was released in our country as a chemotherapeutic agent for infectious diseases. It was also launched in the United States, and began to be widely used in Europe and other countries. With approval from the Minister of Health, the Public Foundation for Microbial Chemistry Research Association (Chairman Shinji Yoshino, Director-General Hanzō Umezawa) was established. At the behest of then Health Minister Ryōgo Hashimoto, the patent revenues from kanamycin were allocated to the foundation's fund.Sources

The Microbial Chemistry Research Institute was established in Kamiozaki, Shinagawa-ku, Tokyo, with Dr. Hanzō Umezawa as director, initiating research activities.Sources

Kasugamycin, effective against rice blast disease, was discovered. Kasugamycin was confirmed to be a low-toxicity, safe pesticide.Sources

To expand research, a new building was added to the Microbial Chemistry Research Institute. It was confirmed that bleomycin showed clinical therapeutic effects against squamous cell carcinoma.Sources

To investigate the distribution of resistant bacteria and plasmids (chromosomal genes) involved in resistance, a branch Epizome Research Institute was established in Fujimi Village, Seta District, Gunma Prefecture.Sources

The 6th International Chemotherapy Conference was held. The antibacterial antibiotic bekamycin was released. The anticancer antibiotic bleomycin was released.Sources

Kasugamycin was released as a specific cure for rice blast disease. The antibacterial antibiotic josamycin was released.Sources

Dr. Atsuji Ichikawa was elected as president of the association. The derivative of kanamycin (jibekasin) that is broadly effective against resistant bacteria including Pseudomonas aeruginosa was synthesized.Sources

To enhance organic synthesis research, the Biological Organic Chemistry Research Institute was established in Ida, Nakahara-ku, Kawasaki City, Kanagawa Prefecture, with Dr. Jun'ō Umezawa as director, initiating research activities.Sources

The antibacterial antibiotic jibekasin was released.Sources

Held the 15th anniversary symposium of the Microbiological Chemistry Research Institute. Proceedings: Jap. J. Antibiot, 30, supplement (1977).Sources

Held the 5th anniversary symposium of the Biological Organic Chemistry Research Institute. Proceedings: Jap. J. Antibiot, 32, supplement (1979).Sources

Peplomycin, an anti‑cancer antibiotic, was released.Sources

The foundation's significant contribution to academic promotion was recognized, and by partially changing donation practices, it became a foundation approved by the Ministers of Health and Education. Held the symposium "Trends in Antibiotic Research". Proceedings: "Trends in Antibiotic Research", edited by H. Umezawa et al., 1982, Japan Antibiotic Research Association. The anti‑cancer antibiotic aclarvacin was released.Sources

For research on chemotherapy and immunotherapy, the Chemotherapy Research Institute, equipped with an animal experiment facility and radiation experiment equipment, was established in Miyamoto, Numazu City, Shizuoka Prefecture.Sources

Founder Dr. Hamou Umezawa passed away at the age of 72. Throughout his life, Dr. Umezawa discovered numerous useful antibiotics such as kanamycin, bleomycin, and kasugamycin, contributing to the development of human health and welfare, and, utilizing broad knowledge in medicine, biology, pharmacy, and organic chemistry, led the global academic community and pioneered various new research fields.Sources

Dr. Tomio Takeuchi (executive director) was elected as the chairman of the association. Held the 25th anniversary symposium of the Microbiological Chemistry Research Institute. Proceedings: "Horizons on Antibiotic Research", edited by B. D. Davis et al., 1988, Japan Antibiotic Research Association. The anti‑cancer antibiotic ubimex (bestatin) was released.Sources

To preserve and exhibit items that tell the achievements of the late Dr. Hamou Umezawa and to promote that knowledge, the Umezawa Hamou Memorial Hall was established in Tamagawa, Setagaya‑ku, Tokyo. The anti‑cancer antibiotic pilarbicin was released.Sources

The antibacterial animal drug ibrosin was released.Sources

The antibacterial antibiotic albecasine was released.Sources

Dr. Jun'ō Umezawa was elected as the president of the association.Sources

To improve the research environment, the Microbiological Chemistry Research Institute Annex, which expanded the conference rooms and library, was established adjacent to the new building. The immunosuppressant gusperimus (deoxysparagin) was released.Sources

A memorial meeting for Dr. Hamou Umezawa was held.Sources

Mr. Shigeru Morioka was elected as the president of the association.Sources

Dr. Tomio Yamakawa (photo) was elected as the president of the association, and Dr. Yoshio Nonomura was elected as the chairman.Sources

In order to streamline the organization of the association, the institute's structure was reformed and names changed. The Microbiological Chemistry Research Institute was renamed the Microbiological Chemistry Research Center, the Biological Organic Chemistry Research Institute became the Hiyoshi Pharmaceutical Chemistry Research Institute, and the Chemotherapy Research Institute became the Numazu Pharmaceutical Medical Science Research Institute. The Epizome Research Institute was closed. Dr. Daisuke Akamatsu was elected as director of the Microbiological Chemistry Research Center.Sources

A 90th anniversary academic lecture on the birth of Dr. Hamou Umezawa was held.Sources

Held the 50th anniversary symposium of the Foundation for Microbiological Chemistry Research.Sources

Renamed the Microbiological Chemistry Research Center to the Microbiological Chemistry Research Institute. The Hiyoshi Pharmaceutical Chemistry Research Institute was renamed the Microbiological Chemistry Research Institute Hiyoshi Branch, and the Numazu Pharmaceutical Medical Science Research Institute was renamed the Microbiological Chemistry Research Institute Numazu Branch. Dr. Akio Nomoto was elected as chairman and director (biological division) of the Microbiological Chemistry Research Institute. Dr. Masakatsu Shibasaki was elected as executive director and director (chemical division) of the Microbiological Chemistry Research Institute. The fifth president, Dr. Tomio Yamakawa, spoke "Microbiological Chemistry Research Association and Me" and a new organizational restructuring was carried out.Sources

It became a public interest foundation, the Microbiological Chemistry Research Association. The Virus Research Division was abolished, and the Basic Biology Research Division was newly established.Sources

Established a Resource Management Office in the Intellectual Property Information Department. Established a Research Cooperation Office in the Intellectual Property Information Department.Sources

The new research building was completed in May. Consequently, the Hiyoshi branch was closed and the organization was restructured.Sources

Reorganized the Molecular Structure Analysis Division into the Structural Biology Research Division and the Molecular Structure Analysis Office. Restructured the Intellectual Property Information Department into the Intellectual Property Information Office. Integrated the Resource Management Office into the Second Biological Activity Division, and merged the Research Cooperation Office into the Secretariat. The Systems Management Department was also merged into the Secretariat. To honor the achievements of the foundation's founder, Dr. Hamuji Umezawa, and to introduce the current Microbial Chemistry Research Association, the Umezawa Hamuji Memorial Museum in Meguro (HUM) was established.Sources

Our institute was ranked first among Japanese research institutions for publishing the highest proportion of high‑quality scientific papers in the natural sciences between 2012 and 2017, according to the Nature Index 2018 Japan.Sources

Reorganized the Molecular Structure Analysis Office into the Molecular Structure Analysis Division and the Intellectual Property Information Office into the Intellectual Property Information Division.Sources

Dr. Takao Shimizu was elected director. Established an Information Management Office in the Intellectual Property Information Department.Sources

Merged the Organic Synthesis Research Division and the Drug Discovery Chemistry Research Division into the Chemistry Department.Sources

History and development of biochemical mechanism of resistance to aminoglycosidic antibiotics and their active derivatives.Sources

§07

News

0 ARTICLES

There is no news.

§08

Public records

GOV
National Tax Agency basic information3010705001652
Source: National Tax Agency Corporate Number Publication Site, basic three itemsSources
Trade name
公益財団法人微生物化学研究会
Trade name (kana)
ビセイブツカガクケンキュウカイ
Name in English
Corporation type
399
Address
〒141-0021 東京都品川区上大崎3丁目14番23号
Postal code
1410021
Prefecture code
13
City code
109
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2015-10-05
Update date
2018-07-10
Change date
2015-10-05
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record
1
Excluded from search
0
Processing type
01
Correction type
1
Trade name image ID
Address image ID
Sequence number
1626253
METI gBizINFO3010705001652
Source: gBizINFO (Ministry of Economy, Trade and Industry)Sources
Corporate number
3010705001652
Trade name
公益財団法人微生物化学研究会
Trade name (kana)
ビセイブツカガクケンキュウカイ
Trade name (alphabet)
Registry closure date
Reason for registry closure
Registered address
東京都品川区上大崎3丁目14番23号
Postal code
1410021
Prefecture
東京都
Prefecture code
13
City or district
品川区
City code
109
Street address
上大崎3丁目14番23号
Organisation type
399
Processing type
01
Correction type
1
Status
Representative
Capital
Employees
Employees (male)
Employees (female)
Business summary
Website URL
Year founded
Business category
Date established
Unified government qualification - grade
Unified government qualification - business items
Update date
2018-07-10
Key information
3010705001652
§09

Sources & updates

SOURCES
↑